Innovative Product Range Nanion Technologies offers advanced automated patch clamp systems including the recent SyncroPatch 384 and giga-ohm seal HTS platforms, along with versatile in vitro systems for membrane pump, transporter, and cell analytics, providing multiple opportunities for customization and integration into research workflows.

Strategic Partnerships Recent collaborations with companies like Metrion Biosciences and Assay.Works expand Nanion's reach into ion channel and transporter research, indicating a growth-oriented approach that can open up joint marketing and co-selling opportunities across drug discovery and assay development sectors.

Market Expansion Nanion’s recent product launches and entry into high-throughput screening with innovations such as Port-a-Patch mini and FLEXcyte 96 demonstrate their focus on scalable solutions, creating sales opportunities in both academic institutions and large pharmaceutical labs seeking efficient electrophysiology tools.

Growing Revenue Potential With revenues estimated between 10 to 25 million dollars and a focused product portfolio, Nanion presents a compelling target for upselling or cross-selling complementary research products and services to existing clients in the biotechnology research industry.

Industry Focus & Trends As a leader in electrophysiology and membrane transporter testing, Nanion is well-positioned to capitalize on the rising demand for precise drug target screening solutions, offering tailored sales strategies aimed at innovation-driven pharmaceutical and biotech companies.